CARDIOME PHARMA CORP's ticker is and the CUSIP is 14159U901. A total of 2 filers reported holding CARDIOME PHARMA CORP in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $655,000 | +1719.4% | 145,000 | +3195.5% | 0.01% | – |
| Q4 2015 | $36,000 | +300.0% | 4,400 | +300.0% | 0.00% | – |
| Q3 2015 | $9,000 | -10.0% | 1,100 | 0.0% | 0.00% | – |
| Q2 2015 | $10,000 | +400.0% | 1,100 | +450.0% | 0.00% | – |
| Q1 2015 | $2,000 | -77.8% | 200 | -80.0% | 0.00% | – |
| Q4 2014 | $9,000 | -88.6% | 1,000 | -88.8% | 0.00% | -100.0% |
| Q3 2014 | $79,000 | +364.7% | 8,900 | +304.5% | 0.00% | – |
| Q2 2014 | $17,000 | -61.4% | 2,200 | -60.7% | 0.00% | -100.0% |
| Q1 2014 | $44,000 | +57.1% | 5,600 | +24.4% | 0.00% | – |
| Q4 2013 | $28,000 | +2700.0% | 4,500 | +1025.0% | 0.00% | – |
| Q3 2013 | $1,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 1,000 | $9,000 | 0.00% |
| Citadel Advisors | 10,400 | $96,000 | 0.00% |